谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Rationale and Design of the LosmApimod to Inhibit P38 MAP Kinase As a TherapeUtic Target and Modify Outcomes after an Acute Coronary Syndrome Trial.

Michelle L. O'Donoghue,Ruchira Glaser,Philip E. Aylward,Matthew A. Cavender,Adam Crisp,Keith A. A. Fox,Ian Laws,Jose L. Lopez-Sendon,P. Gabriel Steg,Pierre Theroux,Marc S. Sabatine,David A. Morrow

American Heart Journal（2015）

引用 38|浏览28
关键词
MAP Kinase,Inflammation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要